{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Canarelli SE"],"funding":["National Institute of General Medical Sciences","NIGMS NIH HHS"],"pagination":["972-982"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9257626"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["3(7)"],"pubmed_abstract":["Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a central enzyme in glycolysis that regulates the Warburg effect in cancer cells. In addition to its role in metabolism, GAPDH is also implicated in diverse cellular processes, including transcription and apoptosis. Dysregulated GAPDH activity is associated with a variety of pathologies, and GAPDH inhibitors have demonstrated therapeutic potential as anticancer and immunomodulatory agents. Given the critical role of GAPDH in pathophysiology, it is important to have access to tools that enable rapid monitoring of GAPDH activity and inhibition within a complex biological system. Here, we report an electrophilic peptide-based probe, SEC1, which covalently modifies the active-site cysteine, C152, of GAPDH to directly report on GAPDH activity "],"journal":["RSC chemical biology"],"pubmed_title":["Monitoring GAPDH activity and inhibition with cysteine-reactive chemical probes."],"pmcid":["PMC9257626"],"funding_grant_id":["R35 GM134964","R35GM134964"],"pubmed_authors":["Weerapana E","Canarelli SE","Morrison MJ","Swalm BM","Larson ET"],"additional_accession":[]},"is_claimable":false,"name":"Monitoring GAPDH activity and inhibition with cysteine-reactive chemical probes.","description":"Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a central enzyme in glycolysis that regulates the Warburg effect in cancer cells. In addition to its role in metabolism, GAPDH is also implicated in diverse cellular processes, including transcription and apoptosis. Dysregulated GAPDH activity is associated with a variety of pathologies, and GAPDH inhibitors have demonstrated therapeutic potential as anticancer and immunomodulatory agents. Given the critical role of GAPDH in pathophysiology, it is important to have access to tools that enable rapid monitoring of GAPDH activity and inhibition within a complex biological system. Here, we report an electrophilic peptide-based probe, SEC1, which covalently modifies the active-site cysteine, C152, of GAPDH to directly report on GAPDH activity ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jul","modification":"2026-05-10T01:35:36.429Z","creation":"2025-02-19T01:10:48.942Z"},"accession":"S-EPMC9257626","cross_references":{"pubmed":["35866162"],"doi":["10.1039/d2cb00091a"]}}